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Purpose.Todescribe a case ofValsalva-related subretinal hemorrhage as a presenting symptomof polypoidal choroidal vasculopathy
(PCV). The patient refrained from treatment against our best advice, and thus this is also a rare case of the natural course of an
untreated PCV.Methods.Case report. Results.A 66-year-old female with a respiratory infection coughed intensely until exhaustion,
after which she developed visual symptoms on the right eye. Primary care ophthalmologist examined the patient on the same day
of the onset of symptoms and referred her to our tertiary medical retinal service for detailed retinal diagnosis including fluorescein
and indocyanine green angiography. The right eye had a large subretinal hemorrhage and pigment epithelium detachment in
the lower temporal arcade with foveal involvement. Against our best advice, the patient refused treatment. In the following 9
months, the BCVA decreased from 68 to 55 ETDRS letters, the subretinal hemorrhage almost regressed, pigment epithelium
detachments persisted, and macular edema, intraretinal cysts, and subretinal fibrosis developed. Conclusions. Although classic
Valsalva retinopathy with preretinal hemorrhage in most cases can be managed by careful observation and no treatment, this case
demonstrates that Valsalva-related subretinal hemorrhage needs different attention and approach.
1. Introduction
Coughing induces a Valsalva-like situation: a deep breath
in, the glottis shuts, the diaphragm presses against the
lungs, and the glottis opens blasting out air. The change
in intrathoracic pressure is 100–250mmHg depending on
the violence of the cough [1]. This reduces cardiac preload,
increasing the venous pressure. First described by Duane in
1972 [2], theValsalva retinopathy classically describes rupture
of small retinal capillaries leading to a preretinal hemorrhage.
Noncomplicated cases aremanaged by careful observation, as
the hemorrhage resolves within months where visual acuity
gradually improves, in most cases into complete recovery [3–
5]. Here, we describe a case of Valsalva-related hemorrhage
of subretinal origin, which turned out to be the presenting
symptom of polypoidal choroidal vasculopathy (PCV), a
disease characterized by polypoidal dilations in the choroid.
2. Case Presentation
A 66-year-old female with a respiratory infection decided to
“get rid of it the phlegm once for all” by coughing strongly
and intensely until exhaustion. During the following hour,
the patient acutely developed blurred vision and light flashes
on the right eye. Primary care ophthalmologist examined
the patient on the same day of the onset of symptoms and
referred her to our tertiary medical retinal service. Our
examination included slit-lamp biomicroscopy, fluorescein
and indocyanine green (ICG) angiography, spectral-domain
optical coherence tomography, and B-scan ultrasound. Best-
corrected visual acuity (BCVA) of each eye was measured
using the Early Treatment of Diabetic Retinopathy Study
(ETDRS) chart. The patient did not have any comorbidities.
Only relevant family history was a now deceased father, who
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Figure 1: Retinal angiography using fluorescein (a) and indocyanine green (b) of the patient’s right eye.The polypoidal lesions are difficult to
visualize due to the massive subretinal hemorrhage. Optical coherence tomography at (c) baseline (BCVA: 68 ETDRS letters, Snellen 6/15),
(d) 3 months (BCVA: 64 ETDRS letters, Snellen 6/19), (e) 6 months (BCVA: 55 ETDRS letters, Snellen 6/24), and (f) 9 months follow-up
(BCVA: 55 ETDRS letters, Snellen 6/24) shows a gradual development of subretinal fibrosis and intraretinal cysts.
had received intravitreal injection treatments for a disease
unknown to the patient.
The right eye had subretinal hemorrhage and pigment
epithelium detachment in the lower temporal arcade with
foveal involvement, and the retinal angiography showed two
hyperfluorescent spots on early-phase ICG but the images
were somewhat blurred due to the large subretinal hemor-
rhage (Figure 1). Intraocular pressure was normal (16mmHg)
and ultrasound found no evidence of tumor.OnOCT images,
we found polyp-like retinal pigment epithelium elevations
(Figure 1). The BCVA was 68 ETDRS letters (Snellen = 6/15).
The left eye was without any pathologies or drusen and the
BCVA was 85 ETDRS letters (Snellen = 6/6).
Against our best advice, the patient initially refused
commencement of intravitreal anti-VEGF treatment. Photo-
dynamic therapy was not possible due to risk of hemorrhage.
We invited the patient for follow-ups with 3-month intervals.
During the total follow-up of 9 months, the BCVA decreased
to 55 ETDRS letters (Snellen = 6/24); the subretinal hem-
orrhage almost regressed; pigment epithelium detachments
persisted; andmacular edema, intraretinal cysts, and subreti-
nal fibrosis developed (Figure 1).
3. Discussion
Valsalva-related preretinal hemorrhages are commonly
caused by macroaneurisms, and subretinal hemorrhages
are commonly seen in choroidal neovascularizations and
especially in cases with retinal angiomatous proliferation.We
here describe a case report of PCV that present with Valsalva-
induced acutely developed subretinal hemorrhage. Although
classic Valsalva retinopathy with preretinal hemorrhage in
most cases can be managed by careful observation, this case
demonstrates that subretinal hemorrhages need different
attention and approach.
PCV is similar to neovascular age-relatedmacular degen-
eration (AMD) in being a disease of the posterior section
with a significant choroidal component. It differs from neo-
vascular AMD in being characterized by polypoidal vascular
dilations with or without an associated branching choroidal
network, by not being associated with drusen maculopathy,
and by often presenting with hemorrhage [6, 7]. This is also
what we see in our case of PCV with polypoidal dilations
and not a single drusen in the fellow eye. The polypoidal
dilations can manifest clinically as quiescent polyps in the
Case Reports in Ophthalmological Medicine 3
absence of subretinal or intraretinal fluid or hemorrhage;
as exudative polyps with exudations leading to intraretinal
cysts, subretinal fluids, and pigment epithelium detachments;
or as hemorrhagic polyps with subretinal hemorrhage or
subretinal pigment epithelium hemorrhage that also may
include any exudative characteristics.The latter, hemorrhagic
type, seems to be the most prevalent [6]. Using our case as an
example, we propose that, in some cases, quiescent polypoidal
lesions may persist asymptomatic until vascular-originated
or mechanical reasons for developing large lesions of a
more symptomatic characteristic. Our patient probably had
quiescent polypoidal lesions without any symptoms until the
Valsalva-induced development of the subretinal hemorrhage.
However, itmust be stressed that hemorrhagic presentation of
PCVs can occur even in the absence of Valsalva, and a cause
of effect relationship in this case report is only suspected due
to a close temporal association. Studies exploring the details
of initial presentation and progression of PCV are needed.
Since the diagnosis of PCV is dependent on retinal
angiography, population-based studies on PCV epidemiol-
ogy are rare. In Asians, PCV accounts for approximately half
of all patients with neovascular AMD [6], while inCaucasians
the prevalence estimates are around 8% [6]. As such, it is a
relatively rare disease in a Danish population. Smoking is a
strong risk factor (OR 4.4) [6], but otherwise little is known.
Abnormal extracellular matrix homeostasis may play a role
as suggested by experimental animal studies and human
serum analyses [6], but the overall picture remains unclear.
From this case point of view, if the polyps are generally
surrounded by a weak and fragile extracellular environment,
it seems reasonable that Valsalva-like events cause subretinal
hemorrhages in cases with PCV.
The natural history of untreated PCV is vision loss and
scarring with hemorrhage as a main reason [8]. Hemorrhagic
PCVs must be treated from the outset, even in suspicious
PCV cases, since otherwise the final visual outcome will be
poor [8]. Although our patient at the end of our follow-up
decided to start anti-VEGF treatment, the game may be over
when fibrosis and scarring develop, and it is important to
remember that timely initiation of treatment and compliance
to treatment are important factors that influence outcomes
from anti-VEGF treatment [9, 10]. Subretinal hemorrhage
damages retinal tissue and should be avoided. Although anti-
VEGF treatment of PCV does provide good clinical results
[11], management of subretinal hemorrhage can also be
achieved at an acceptable level using pneumatic displacement
and tissue plasminogen activator to remove remaining blood
clots [12].
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